Alimera Sciences (NASDAQ: ALIM)
Alimera Sciences Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Alimera Sciences Company Info
Alimera Sciences, Inc. engages in the research and development of biopharmaceutical products. It operates through the following geographical segments: U.S. and International. The firm focuses on the development of ophthalmic pharmaceuticals for the treatment of diabetic macular edema, wet and dry age-related macular degeneration and retinal vein occlusion. Its products include ILUVIEN and NADPH Oxidase Inhibitors. The company was founded by Daniel C. Myers and David R. Holland on June 4, 2003 and is headquartered in Alpharetta, GA.
News & Analysis
Today’s Top Biotech Stories: Lexicon, Alimera, and Akebia
Lexicon, Alimera, and Akebia are the top stories to watch in the biotech sector this Monday morning.
Why AK Steel, Idenix Pharmaceuticals, and Alimera Sciences Are Today's 3 Best Stocks
The S&P 500 breaks a three-day losing streak as AK Steel, Idenix Pharmaceuticals, and Alimera Sciences all rocket higher by double-digits.
2 Stocks Stopping the Presses
These companies made big headlines -- what does it mean to you?
Alimera Annihilates Its Doubters
European approval of Iluvien sends shares skyrocketing.
Health Care's 5 Worst November Flops
These stocks had a terrible month.
5 of Last Week's Biggest Losers
These five stocks only made shorts some serious money last week.
These 2 Biotechs Got Crushed
Highlighting the day's health-care stories critical to investors.
Hidden Stocks for High Returns
These underrated stocks could be tomorrow's big winners.
Valuation
Earnings Transcripts
Alimera Sciences, inc (ALIM) Q3 2021 Earnings Call Transcript
ALIM earnings call for the period ending September 30, 2021.
Alimera Sciences, inc (ALIM) Q2 2021 Earnings Call Transcript
ALIM earnings call for the period ending June 30, 2021.
Alimera Sciences Inc (ALIM) Q1 2021 Earnings Call Transcript
ALIM earnings call for the period ending March 31, 2021.
Alimera Sciences Inc (ALIM) Q4 2020 Earnings Call Transcript
ALIM earnings call for the period ending December 31, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.